Label: GUAIFENESIN 400MG CAPLETS- guaifenesin tablet
- NDC Code(s): 77333-360-10, 77333-360-25
- Packager: Gendose Pharmaceuticals, LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated January 8, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT (IN EACH CAPLET)
- PURPOSE
- USES
-
WARNINGS
ASK DOCTOR BEFORE USE IF YOU HAVE:
- PERSISTENT OR CHRONIC COUGH SUAH AS OCCURS WITH SMOKING, ASTHMA, CHRONIC BRONCHITIS OR EMPHASEMA (MUCUS)
- COUGH ACCOMPANIED BY EXCESSIVE PHLEGM
WHEN USING THIS PRODUCT
- DO NOT EXCEED RECOMMENDED DOSAGE
- DO NOT USE FOR MORE THAN 7 DAYS
STOP USE AND ASK A DOCTOR IS
- COUGH LASTS FOR MORE THAN 7 DAYS, RECURS, OR IS ACCOMPANIED BY FEVER, RASH, OR PERSISTENT HEADACHE. THESE COULD BE SIGNS OF A SERIOUS CONDITION.
IF PREGNANT OR BREAST FEEDING, ASK A HEALTH PROFESSIONAL BEFORE USE.
- KEEP OUT OF REACH OF CHILDREN
- DIRECTIONS
- OTHER INFORMATION
- INACTIVE INGREDIENTS
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
GUAIFENESIN 400MG CAPLETS
guaifenesin tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:77333-360 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN 400 mg Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) MAGNESIUM STEARATE (UNII: 70097M6I30) MALTODEXTRIN (UNII: 7CVR7L4A2D) STEARIC ACID (UNII: 4ELV7Z65AP) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) POVIDONE (UNII: FZ989GH94E) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) Product Characteristics Color white Score no score Shape OVAL (CAPLET) Size 14mm Flavor Imprint Code G400 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:77333-360-10 100 in 1 BOX 09/02/2022 1 NDC:77333-360-25 1 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M012 09/02/2022 Labeler - Gendose Pharmaceuticals, LLC (080257510)